Global Automation In Biopharma Industry Market Growth 2024, Forecast To 2033
8 Mar, 2024
Automation in the biopharma industry is on the rise, with market size reaching $1.94 billion in 2023, poised to grow to $2.06 billion in 2024 at a 6.4% CAGR. Factors include process efficiency needs and biologics development. The market is expected to reach $2.66 billion by 2028, driven by data integrity enhancements and modular bioprocessing facilities, with trends like AI integration and sustainability emphasis.
Global Automation In Biopharma Industry Market Key Driver
The automation in the biopharma industry market is growing with the increasing adoption of robots in pharmaceutical manufacturing. With robots playing a crucial role in enhancing productivity and safety in pharmaceutical production, there's a growing market for automation solutions in the biopharma industry.
Get A Free Sample Of The Global Automation In Biopharma Industry Market ReportGlobal Automation In Biopharma Industry Market Segments
The automation in biopharma industry market covered in this report is segmented –
1) Technology:Automation Technology, Digitization Technology
2) Component:Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase
3) Application:Clinical Phase, Drug Discovery Phase, Production Phase
By Geography: The countries covered in the automation in biopharma industry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
North America was the largest region in the automation in biopharma industry market in 2023. The regions covered in the automation in biopharma industry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Automation In Biopharma Industry Industry Players
F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Danaher Corporation; ABB Ltd; Siemens Healthineers AG; Emerson Electric Co.; Becton Dickinson and Company (BD); Corning Incorporated; Rockwell Automation Inc.; Agilent Technologies Inc.; PerkinElmer Inc.; Sartorius AG; bioMérieux SA; Mettler-Toledo International Inc.; Beckman Coulter Inc.; Waters Corporation; Pall Corporation; Bruker Corporation; Qiagen N.V.; Eppendorf AG; Tecan Group Ltd.; Promega Corporation; Brooks Automation Inc.; Omron Automation; Hamilton Company; Integra Biosciences AG; Gilson Inc.; Analytik Jena AG; BioTek Instruments Inc.
Get The Full Global Automation In Biopharma Industry Market Report
Automation In Biopharma Industry Market Overview
Automation in the biopharma industry refers to integrating advanced technologies and robotics into various stages of the biopharmaceutical manufacturing process. It includes using automated systems and equipment to carry out tasks traditionally performed by humans, intending to increase efficiency, accuracy, and productivity in producing biopharmaceutical products.